In glioma, IGF‐1 could modulate miR‐513a‐5p expression to affect the NEDD4L/Wnt/β‐catenin signalling pathway and desensitize glioma cells to temozolomide.31, 32, 33. This evidence concerns the gene NEDD4L and central nervous system cancer.